Get started
AlloVir, Inc.AlloVir, Inc.AlloVir, Inc.

AlloVir, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

ALVR chart


Full chart

ALVR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪58.04 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.8765 USD
Net income (FY)
‪−190.42 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪51.78 M‬
Beta (1Y)
−0.78

Employees


Employees (FY)
112
Change (1Y)
+6 +5.66%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.70 M‬ USD

About AlloVir, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Diana M. Brainard
Website
allovir.com
Headquarters
Waltham
Founded
2013
FIGI
BBG00P80SH34
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALVR news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALVR is 0.4856 USD — it has decreased by −1.15% in the past 24 hours. Watch AlloVir, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange AlloVir, Inc. stocks are traded under the ticker ALVR.
ALVR stock has risen by 0.20% compared to the previous week, the month change is a −21.09% fall, over the last year AlloVir, Inc. has showed a −77.41% decrease.
ALVR reached its all-time high on Dec 23, 2020 with the price of 48.9600 USD, and its all-time low was 0.5100 USD and was reached on Nov 26, 2024. View more price dynamics on ALVR chart.
See other stocks reaching their highest and lowest prices.
ALVR stock is 7.45% volatile and has beta coefficient of −0.78. Track AlloVir, Inc. stock price on the chart and check out the list of the most volatile stocks — is AlloVir, Inc. there?
Today AlloVir, Inc. has the market capitalization of ‪58.36 M‬, it has increased by 1.20% over the last week.
Yes, you can track AlloVir, Inc. financials in yearly and quarterly reports right on TradingView.
AlloVir, Inc. is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
ALVR net income for the last quarter is ‪−4.13 M‬ USD, while the quarter before that showed ‪−6.08 M‬ USD of net income which accounts for 32.09% change. Track more AlloVir, Inc. financial stats to get the full picture.
No, ALVR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has 112.00 employees. See our rating of the largest employees — is AlloVir, Inc. on this list?
Like other stocks, ALVR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AlloVir, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AlloVir, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AlloVir, Inc. stock shows the sell signal. See more of AlloVir, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.